Pricing Log in Create free account
Friday 6 November 2026 Export LGND’s income statement to Excel — free account

Ligand Pharmaceuticals Incorporated

LGND Healthcare Biotechnology

Ligand Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $268.1 million, up 60.4% from fiscal 2024.

Revenue
−31.8%
EPS
−123.9%
Free cash flow
−268.5%
Total debt
+52.6%

Quarter to September 2026, against a year earlier

306.43 7.43 +2.48%
Market cap
$6.0B
P/E
116×
Fwd P/E
88.3×
Dividend yield
—
F-score
6/9
Altman Z
5.45
Beneish M
−4.02
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Ligand Pharmaceuticals Incorporated (LGND) Book value per share

Alert me on Book value per share

Ligand Pharmaceuticals Incorporated's book value per share at the end of fiscal 2025 was 52.6×, up 15.9% from 45.4× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 48.2×. Over the past ten years it has ranged from 12.0× (fiscal 2015) to 52.6× (fiscal 2025) — the current reading is the highest in ten years. Ligand Pharmaceuticals Incorporated ranks 14th of 611 Biotechnology companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 52.6× 15.85%
FY2024 45.4× 12.05%
FY2023 40.5× 14.39%
FY2022 35.4× (28.27%)
FY2021 49.4× 12.64%
FY2020 43.8× 8.53%
FY2019 40.4× 52.37%
FY2018 26.5× 39.45%
FY2017 19.0× 16.02%
FY2016 16.4× 36.65%

Quarterly newest first

Period Book value per share Change
Sep 2026 48.2× (0.09%)
Jun 2026 48.2× (3.86%)
Mar 2026 50.2× (4.64%)
Dec 2025 52.6× 8.38%
43 more quarters

Against its own ten years

Low 12.0× High 52.6×
Ten-year median 40.4×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
LGND Ligand Pharmaceuticals Incorporated 48.2×
BLTE Belite Bio, Inc. Sponsored ADR compare 19.3×
ORKA Oruka Therapeutics, Inc. compare 17.7×
CGON CG Oncology, Inc. compare 11.7×
IMVT Immunovant, Inc. compare 3.6×
IONS Ionis Pharmaceuticals, Inc. compare 2.7×
KOD Kodiak Sciences Inc. compare 1.0×
MIRM Mirum Pharmaceuticals, Inc. compare −0.8×
PTCT PTC Therapeutics, Inc. compare −2.3×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on LGND